...
机译:先进的高级浆液卵巢癌:肿瘤组织和患者预后的KLK13和KLK14 mRNA水平的逆关联
Tech Univ Munich Dept Obstet &
Gynecol Clin Res Unit Ismaninger Str 22 D-81675 Munich Germany;
Tech Univ Munich Dept Obstet &
Gynecol Clin Res Unit Ismaninger Str 22 D-81675 Munich Germany;
Med Labor Ostsachsen Dresden Germany;
Tech Univ Munich Dept Obstet &
Gynecol Clin Res Unit Ismaninger Str 22 D-81675 Munich Germany;
Tech Univ Munich Dept Obstet &
Gynecol Clin Res Unit Ismaninger Str 22 D-81675 Munich Germany;
Hop St Louis INSERM Paris France;
Tech Univ Munich Dept Obstet &
Gynecol Clin Res Unit Ismaninger Str 22 D-81675 Munich Germany;
Tech Univ Munich Inst Pathol Munich Germany;
Tech Univ Munich Dept Obstet &
Gynecol Clin Res Unit Ismaninger Str 22 D-81675 Munich Germany;
Tech Univ Munich Dept Obstet &
Gynecol Clin Res Unit Ismaninger Str 22 D-81675 Munich Germany;
Tech Univ Munich Dept Obstet &
Gynecol Clin Res Unit Ismaninger Str 22 D-81675 Munich Germany;
KLK13; KLK14; Ovarian cancer; Quantitative PCR; mRNA expression;
机译:先进的高级浆液卵巢癌:肿瘤组织和患者预后的KLK13和KLK14 mRNA水平的逆关联
机译:最大标准化摄取值的肿瘤到背景比率不能表明先进高级浆液癌患者的预后
机译:血管内皮生长因子受体2(VEGFR2)与晚期高级浆液癌患者(HGSOC)的长期存活相关:肿瘤库卵巢癌(TOC)联盟的研究
机译:IDO用作浆液性卵巢癌细胞基因表达谱中预后不良的标志物
机译:溃疡性结肠炎相关大肠癌和高级别浆液性卵巢癌癌前突变的双重测序表征。
机译:激肽释放酶相关肽酶KLK10和KLK11的肿瘤组织蛋白表达水平升高与晚期高级别浆液性卵巢癌患者的预后相关
机译:基于数字病理学的细胞和组织水平形态学特征研究血浆卵巢肿瘤和高级浆液癌